Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMB-001 for Smoking Cessation
NCT04868253Phase 3Unknown
- Sponsor
- Rose Research Center
- Start
- May 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metyrapone + oxazepam in Tobacco Use Disorder (TUD), sponsored by Rose Research Center. Status: unknown.
02
Drugs
metyrapone + oxazepam
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04868253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04868253.